Differential effects of malignant mesothelioma cells on THP-1 monocytes and macrophages

Valerio Izzi1, Valerio Chiurchiù, Fabiola D'Aquilio

  • 1Department of Experimental Medicine and Biochemical Sciences, University of Rome Tor Vergata, I-00133 Rome, Italy. valerioizzi@libero.it

Insights

Malignant mesothelioma cells alter immune cells. These tumor cells can change monocytes into an inflammatory state and macrophages into an immunosuppressive one, impacting cancer immunity.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Malignant mesothelioma (MM) is a fatal cancer associated with impaired immune response.
  • MM tumors are infiltrated by leukocytes, particularly macrophages.
  • Understanding tumor-associated immune modulation is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate how malignant mesothelioma cells influence the inflammatory phenotype of monocytes and macrophages.
  • To determine if MM cells promote the differentiation of monocytes into tumor-supporting macrophages.
  • To elucidate the mechanisms by which MM cells affect immune cell function.

Main Methods:

  • Utilized human THP-1 monocytes and macrophages as an in vitro model.
  • Co-cultured THP-1 cells with human malignant mesothelioma cells.
  • Analyzed the phenotypic and functional changes in monocytes and macrophages post-exposure to MM cells.

Main Results:

  • MM cells were shown to polarize monocytes towards an altered inflammatory phenotype.
  • MM cells induced macrophages to adopt an immunosuppressive phenotype.
  • Monocytes exposed to MM cells retained a 'memory' that influenced their subsequent differentiation into macrophages.

Conclusions:

  • Malignant mesothelioma cells exert distinct, cell-specific effects on monocyte and macrophage differentiation and function.
  • MM cells actively modulate the tumor microenvironment by altering immune cell phenotypes.
  • Characterizing these MM-driven immune alterations is vital for designing novel immunotherapeutic strategies against malignant mesothelioma.